Pharmaceuticals, Biotechnology and Life Sciences
TORTOLA, British Virgin Islands–(BUSINESS WIRE)–Juvenescence, a life sciences company developing therapeutics and technologies to treat diseases of aging and increase…
Enables new sites to participate in the European Phase III SALAMANDER trials LONDON–(BUSINESS WIRE)–Rexgenero, a regenerative medicine company developing advanced…
Transgene confirms that the study’s primary
endpoint (objective response rate – ORR) on a minimum of 35 evaluable
patients will be reported in Q4 2019.
The LYRICA Pediatric Epilepsy Program is composed of six studies in
patients with epilepsy evaluating LYRICA as adjunctive therapy, five of
which have been completed.
Jakafi is the first and only FDA-approved treatment for patients with
steroid-refractory acute graft-versus-host disease (GVHD)
PHILADELPHIA–(BUSINESS WIRE)–Wharton Research Data Services (WRDS), the leading data research platform and business intelligence tool for corporate, academic and government…
DUBLIN–(BUSINESS WIRE)–The “Orphan Drugs – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The report provides…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–Technavio’s latest market research report on the global biosimulation market predicts the market to witness a CAGR…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global gene therapy for inherited genetic disorders market is expected to post a CAGR of about…
DUBLIN–(BUSINESS WIRE)–The “Global Hearing Implant Market – Analysis By Type (Cochlear Implant, Bone Anchored Hearing Aid, Acoustic Brainstem Implant, Middle…